摘要
目的观察对比瑞舒伐他汀与阿托伐他汀治疗冠心病的效果。方法将我院2015年度收治的58例冠心病患者作为本次实验观察对象,随机划分为A、B两组各29例,分别采用瑞舒伐他汀与阿托伐他汀进行治疗,观察两种药物对冠心病的治疗效果。结果用药后A组患者的心功能恢复情况优于B组(P<0.05)。结论相比阿托伐他汀,瑞舒伐他汀具有新型、高效、安全等优势,效果令人满意。
Objective To observe the clinical effect of rosuvastatin and atorvastatin in the treatment of coronary heart disease（CHD）. Methods 58 of CHD patients treated in 2015 in our hospital were selected. The subjects were randomly divided into two groups,29 cases each group. Two groups respectively took rosuvastatin and atorvastatin. The clinical effect for two groups was observed. Results After treatment,the cardiac function for group A was significantly better than that of group B（P 〈0.05）. Conclusion Compared with atorvastatin,rosuvastatin has more efficient and safer effects in CHD patients.
出处
《中国卫生标准管理》
2016年第19期99-100,共2页
China Health Standard Management
